A retrospective observational cohort study of Basiliximab compared to R-ATG on acute rejection risk in high immunological risk renal transplant recipients
Latest Information Update: 25 Oct 2021
At a glance
- Drugs Basiliximab (Primary) ; Antithymocyte globulin
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 25 Oct 2021 New trial record
- 01 Sep 2021 Results presented at the 20th Congress of the European Society for Organ Transplantation.